JNJ-26481585, a novel "second-generation" oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activity. [electronic resource]
Producer: 20100322Description: 6841-51 p. digitalISSN:- 1557-3265
- Animals
- Antineoplastic Agents -- administration & dosage
- Apoptosis
- Cell Proliferation
- Colonic Neoplasms -- pathology
- Fluorouracil -- pharmacology
- Histone Deacetylase Inhibitors -- administration & dosage
- Histones -- chemistry
- Humans
- Hydroxamic Acids -- administration & dosage
- Inhibitory Concentration 50
- Liver Neoplasms -- secondary
- Luminescent Proteins -- chemistry
- Male
- Mice
- Neoplasm Metastasis
- Neoplasm Transplantation
- Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.